Guangdong Biolight Meditech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.73%

Guangdong Biolight Meditech Co Ltd (300246) has an Asset Resilience Ratio of 0.73% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300246 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥18.48 Million

≈ $2.70 Million USD Cash + Short-term Investments

Total Assets

CN¥2.53 Billion

≈ $369.92 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Guangdong Biolight Meditech Co Ltd's Asset Resilience Ratio has changed over time. See Guangdong Biolight Meditech Co Ltd (300246) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Biolight Meditech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Guangdong Biolight Meditech Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥18.48 Million	0.73%
Total Liquid Assets	CN¥18.48 Million	0.73%

Asset Resilience Insights

Limited Liquidity: Guangdong Biolight Meditech Co Ltd maintains only 0.73% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Biolight Meditech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Biolight Meditech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for Guangdong Biolight Meditech Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Guangdong Biolight Meditech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	10.56%	CN¥263.97 Million ≈ $38.63 Million	CN¥2.50 Billion ≈ $365.66 Million	+7.32pp
2020-12-31	3.25%	CN¥52.20 Million ≈ $7.64 Million	CN¥1.61 Billion ≈ $235.18 Million	+0.13pp
2019-12-31	3.12%	CN¥30.00 Million ≈ $4.39 Million	CN¥961.46 Million ≈ $140.69 Million	+2.25pp
2016-12-31	0.87%	CN¥6.00 Million ≈ $877.99K	CN¥686.57 Million ≈ $100.47 Million	+0.19pp
2015-12-31	0.69%	CN¥4.00 Million ≈ $585.33K	CN¥580.65 Million ≈ $84.97 Million	--

pp = percentage points

About Guangdong Biolight Meditech Co Ltd

SHE:300246 China Medical Devices

Market Cap

$685.28 Million

CN¥4.68 Billion CNY

Market Cap Rank

#10953 Global

#3239 in China

Share Price

CN¥17.70

Change (1 day)

+4.06%

52-Week Range

CN¥7.29 - CN¥17.70

All Time High

CN¥30.12